+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Anti-Obesity Drugs Market Research Reports

From
Anti-Obesity Drugs: Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs: Global Strategic Business Report

  • Report
  • October 2023
  • 264 Pages
  • Global
From
From
From
Obesity - Pipeline Insights, 2022 - Product Thumbnail Image

Obesity - Pipeline Insights, 2022

  • Clinical Trials
  • November 2022
  • 260 Pages
  • Global
From
Global Anti-obesity Drugs Market 2023-2027 - Product Thumbnail Image

Global Anti-obesity Drugs Market 2023-2027

  • Report
  • November 2022
  • 120 Pages
  • Global
From
Antiobesity Global Market Report 2023 - Product Thumbnail Image

Antiobesity Global Market Report 2023

  • Report
  • February 2023
  • 175 Pages
  • Global
From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • October 2023
  • 184 Pages
  • Global
From
From
Loading Indicator

The Anti-Obesity Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs designed to reduce or prevent obesity. These drugs are typically prescribed to individuals who are overweight or obese and are at risk of developing health complications due to their weight. Commonly prescribed anti-obesity drugs include orlistat, lorcaserin, and phentermine. These drugs work by suppressing appetite, increasing metabolism, or blocking the absorption of fat. The Anti-Obesity Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Novo Nordisk, Sanofi, Pfizer, and Merck. These companies are constantly developing new drugs and treatments to meet the needs of their customers. Show Less Read more